Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
| Plasmid Name | Proper Citation | Insert Name | Organism | Bacterial Resistance | Defining Citation |
Comments |
|||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
pAM1414 Resource Report Resource Website |
RRID:Addgene_40237 | promoterless luxAB reporter | Synechococcus elongatus PCC 7942 | Spectinomycin | PMID:10812624 | NS1 vector Lux Genes: luxAB cloning sites NotI and BamHI Blunted (by Klenow) SalI-PvuII luxAB fragment (from pLAV1) was cloned in the SmaI site of pAM1303. SalI site is approximately 135bp upstream of luxA ATG within the luxD reading frame. You can clone promoters upstream of luxAB in NotI or BamHI sites. | Vector Backbone:pAM1303; Vector Types:Cyanobacteria cloning vector; Bacterial Resistance:Spectinomycin | Addgene | 2026-11-14 12:57:05 | 0 | |
|
pET21b-LOV-ipaA Resource Report Resource Website 1+ mentions |
RRID:Addgene_40236 | LOV-ipaA | Synthetic | Ampicillin | PMID:22520757 | This vector encodes a photo-activable caged form of the vinculin binding ipaA peptide. Regarding the hybridized region, the first ten residues of the ipaA VBS1 helical peptide were identified as a close match to the last ten residues of the AsLOV2 Jα helix; five of the ten positions are identical, and the hydrophobic residues on the Jα helix that make critical contacts with the AsLOV2 domain beta-sheet at residues 539, 542, and 543 are conserved in the alignment with ipaA. Additionally, residues in the ipaA sequence that make extensive contacts with vinculin are conserved in the alignment (Ile 612, Ala 615, Ala 616, and Val 619 in ipaA). Side-chain optimization simulations were used to thread the first ten residues of ipaA onto the last ten residues of the Jα helix. The 540 position on the Jα helix was converted to isoleucine. The LOV-ipaA gene was synthesized with a six histidine N-terminal tag (Genscript, Piscataway, NJ, USA) and cloned into the pET21b vector. Protein coding sequence of LOV-ipaA: MHHHHHHGSLATTLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNCRFLQGPETDRATVRKIRDAIDNQTEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVRDAAEREGVMLIKKTANNIIKAAKDVTTSLSKVLKNIN | Backbone Marker:EMD Biosciences; Backbone Size:5442; Vector Backbone:pET-21b(+); Vector Types:Bacterial Expression; Bacterial Resistance:Ampicillin | Jα helix region hybridized (AsLOV2 aa 537-546/ipaA aa 610-619), residue 540 changed to isoleucine | Addgene | 2026-11-14 12:57:05 | 1 |
|
pRS413-GAL1-yEGFP1 Resource Report Resource Website 1+ mentions |
RRID:Addgene_40235 | yEGFP1 | Ampicillin | yEGFP contains a M233I point mutation. Depositor states that this mutation does not affect yEGFP function. | Backbone Size:5667; Vector Backbone:pRS413; Vector Types:Bacterial Expression; Bacterial Resistance:Ampicillin | Addgene | 2026-11-14 12:57:05 | 3 | |||
|
CD40L-MIEG-hCD4 (hCD4-CD40L) Resource Report Resource Website 1+ mentions |
RRID:Addgene_40355 | CD40L | Mus musculus | Ampicillin | PMID:19405121 | The CD40-ligand (CD40L)-expressing retroviral vector was constructed by PCR amplification of cDNA from anti-CD3 activated mouse T cells with the following primers for CD40-ligand: sense 5'-CTTTCAGTCAGCATGATAGAAACA-3' and antisense 5'-TCAGAGTTTGAGTAAGCCAAAAGA-3'; these primers were used to amplify the complete coding region of mouse CD40 ligand. The CD40-ligand gene was then reamplified with primers containing XhoI and NotI sites and then cloned via XhoI and NotI sites into a retroviral vector expressing human CD4. | Backbone Marker:Addgene plasmid 40569; Vector Backbone:MIEG-hCD4; Vector Types:Retroviral; Bacterial Resistance:Ampicillin | Addgene | 2026-11-14 12:57:06 | 2 | |
|
pMIEG3-JunDN Resource Report Resource Website 1+ mentions |
RRID:Addgene_40350 | Jun dominant negative | Homo sapiens | Ampicillin | PMID:15699140 | The Jun dominant negative vector was made by first preparing a version of c-Jun with the first 122 aa deleted. This cDNA was amplified by PCR from human c-Jun with the following primers: sense, 5-AAAAAA-GAATTC-ATGACTAGCCAGAACACGCTGCCCAGCGTC-3; antisense, 5-AAAAAA-GAATTC-TCAGCTGGCATAGTCAGGCACGTCATAAGGATAGCTAAATGTTTGCAAC-3. The antisense primer adds a hemagglutinin tag to the C terminus of c-Jun. The PCR product was then cut with EcoRI and cloned into the retroviral vector pMIEG3. | Backbone Marker:David A. Williams (PMID: 10961859); Vector Backbone:pMIEG3; Vector Types:Mammalian Expression, Retroviral; Bacterial Resistance:Ampicillin | first 122 amino acids deleted | Addgene | 2026-11-14 12:57:06 | 7 |
|
pCXN2-BCL6 (CXN-BCL6) Resource Report Resource Website 1+ mentions |
RRID:Addgene_40346 | BCL6 | Homo sapiens | Ampicillin | PMID:12165517 | CXN-BCL-6 was constructed by inserting the human BCL-6 cDNA from pBS-BCL-6 full length (FL) via SalI ends into the XhoI site in the pCXN2 expression vector. The pCXN2 (CXN) vector was obtained from Dr. K. Ozato (National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD) and consists of the human BCL-6 cDNA driven by a hybrid β-actin-CMV promoter. | Backbone Marker:Niwa, Yamamura, and Miyazaki (PMID: 1660837); Backbone Size:5200; Vector Backbone:pCXN2; Vector Types:Mammalian Expression; Bacterial Resistance:Ampicillin | Addgene | 2026-11-14 12:57:06 | 3 | |
|
pCIneoFH human RASSF6 Resource Report Resource Website |
RRID:Addgene_40344 | RASSF6 | Homo sapiens | Ampicillin | PMID:19797269 | pCIneoFH vector has the sequence NheI-FLAG-His6-EcoRI-MluI-XbaI-SalI-SmaI-NotI. A digest with NheI and SalI will excise the insert with tags. | Backbone Marker:Promega; Vector Backbone:pCI-neo (modified); Vector Types:Mammalian Expression; Bacterial Resistance:Ampicillin | Addgene | 2026-11-14 12:57:06 | 0 | |
|
RSVpGL3 (RSV promoter-luciferase in pGL3-basic) Resource Report Resource Website 1+ mentions |
RRID:Addgene_40343 | RSV promoter | Rous sarcoma virus (RSV) | Ampicillin | PMID:12165517 | The Rous sarcoma virus (RSV) promoter reporter was constructed by isolating the RSV promoter from pRc/RSV (Invitrogen) via BglII and HindIII sites and cloned into pGL3-basic by the same sites. | Backbone Marker:Promega; Backbone Size:4818; Vector Backbone:pGL3-basic; Vector Types:Mammalian Expression, Luciferase; Bacterial Resistance:Ampicillin | Addgene | 2026-11-14 12:57:06 | 2 | |
|
3xAP1pGL3 (3xAP-1 in pGL3-basic) Resource Report Resource Website 50+ mentions |
RRID:Addgene_40342 | 3xAP-1 | Ampicillin | PMID:12165517 | The 3 AP-1 reporter contains three canonical AP-1 binding sites (TGACTCA) upstream of a minimal promoter fragment containing a TATA box in the luciferase reporter plasmid pGL3-basic. | Backbone Marker:Promega; Backbone Size:4818; Vector Backbone:pGL3-basic; Vector Types:Mammalian Expression, Luciferase; Bacterial Resistance:Ampicillin | Contains three canonical AP-1 binding sites (TGACTCA) upstream of a minimal promoter fragment containing a TATA box | Addgene | 2026-11-14 12:57:06 | 54 | |
|
pCGN-BCL-6Δ (pCGN-BCL6-delta) Resource Report Resource Website |
RRID:Addgene_40338 | BCL-6Δ | Homo sapiens | Ampicillin | PMID:10973278 | The expression plasmid pCGN-BCL-6Δ was constructed by digesting the BCL-6 cDNA with EcoRI, deleting the 3' region, and cloning the remaining cDNA into pCGN. The BCL-6Δ is missing four of six zinc fingers and does not bind to a consensus BCL-6 probe in a gel shift assay (A. L. Dent, unpublished data). Note, the cloning and ligation adds the following residues after aa595 of BCL6: RYQAYRYRRPGYR | Backbone Marker:Masafumi Tanaka and Winship Herr (PMID: 2302733); Backbone Size:7500; Vector Backbone:pCGN; Vector Types:Mammalian Expression; Bacterial Resistance:Ampicillin | Missing four of six zinc fingers (see note below); contains aa 1-595 | Addgene | 2026-11-14 12:57:06 | 0 |
|
pFRT/FLAG/HA-DEST PUM2 Resource Report Resource Website 1+ mentions |
RRID:Addgene_40292 | Pumilio homolog 2 | Homo sapiens | Ampicillin | PMID:20371350 | Note that there are some cloning scars flanking the insert (see Addgene sequence), but they will not affect plasmid function. | Backbone Size:5372; Vector Backbone:pFRT/FLAG/HA-DEST; Vector Types:Mammalian Expression; Bacterial Resistance:Ampicillin | Addgene | 2026-11-14 12:57:05 | 1 | |
|
pCalN-ddGFP-A Resource Report Resource Website 1+ mentions |
RRID:Addgene_40290 | Calnexin | Homo sapiens | Ampicillin | PMID:23656278 | Addgene sequencing results find I474N in calnexin translation compared to reference sequence NP_001737.1 | Backbone Marker:Invitrogen; Vector Backbone:pcDNA3.1; Vector Types:Mammalian Expression; Bacterial Resistance:Ampicillin | Addgene | 2026-11-14 12:57:05 | 1 | |
|
pMCP-MU-Luc (MCP-1 mut promoter in pGL3-basic) Resource Report Resource Website |
RRID:Addgene_40325 | MCP-1 promoter (mutated) | Mus musculus | Ampicillin | PMID:10973278 | Note: Addgene NGS results identified an extra ~500 bp region upstream of the expected promoter, which contains a CMV enhancer feature. It is unknown what impact the region may have on plasmid function, but the extra sequence appears to have been present in the original sample received by Addgene. A plasmid containing the mouse MCP-1 promoter driving luciferase (pMCP-Luc) was constructed from pGL3-basic (Promega, Madison, WI) and a PCR-generated MCP-1 promoter fragment. A proofreading competent Taq reagent (AccuTaq, Sigma) was used to ensure high fidelity PCR. 1.2 kb of the MCP-1 promoter (GenBank Accession no. U12470) was obtained by PCR of C57BL/6 mouse DNA with the following primers: 5′–TCATGTATATGGCTTTCCAGGTCT–3′ (sense strand, distal to transcription start) 5′–TGCACTTCTGGCTGCTCTGAG GCA–3′ (antisense strand, proximal to transcription start) The PCR product terminates 28-bp downstream of the MCP-1 TATA site. XmaI and XhoI sites were added to the MCP-1 promoter by a second round of PCR with the primers: 5′–ATATCACCCGGGTCATGTATATGGCTTTCCAGGTCT–3′ 5′–TAGATTCTCGAGTGCACTTCTGGCTGCTCTGAGGCA–3′ and XmaI and XhoI were used to clone the MCP-1 promoter fragment into pGL3-basic. For the construction of the MCP-1 mutant promoter, the BCL-6 site was mutated by a two step PCR–based strategy using the above flanking primers and the following complementary primers to mutate the BCL-6 site: 5′–TCTCTCTTCCACTTCCT[TT]AAACA–3′ 5′–TGTTT[AA]AGGAAGTGGAAGAGAGA–3′ (mutated bases are in brackets) The mutant promoter was cloned into pGL3 via XhoI and XmaI. The wild-type and mutant MCP-1 promoter sequences were verified by sequencing. | Backbone Marker:Promega; Backbone Size:4818; Vector Backbone:pGL3-basic; Vector Types:Mammalian Expression, Luciferase; Bacterial Resistance:Ampicillin | contains MCP-1 promoter region through the nucleotides 28-bp downstream of the MCP-1 TATA site. Sequence has two base changes from the wild-type MCP-1 promoter around the -150 bp position (see note below). | Addgene | 2026-11-14 12:57:06 | 0 |
|
2C::tdTomato Reporter Resource Report Resource Website 10+ mentions |
RRID:Addgene_40281 | 2C Promoter (2-cell stage promoter) | Mus musculus | Ampicillin | PMID:22722858 | The CMV promoter from the parent pcDNA plasmid was removed with MluI and HindIII, leaving approx. 6400kb backbone. The 2C promoter was put in its place (730bp) using the same sites. Hence, the full plasmid is 7129bp. The promoter is active shortly after fertilization of mouse embryos to about the 8-cell stage. It is also on in a subset of MESCs & miPSCs. | Backbone Marker:Invitrogen/Life Tech; Backbone Size:6400; Vector Backbone:pcDNA Hygro; Vector Types:Mammalian Expression; Bacterial Resistance:Ampicillin | Addgene | 2026-11-14 12:57:05 | 15 | |
|
pDDYFP-B Resource Report Resource Website |
RRID:Addgene_40289 | ddYFP-B | Synthetic | Ampicillin | PMID:23656278 | Backbone Marker:Invitrogen; Backbone Size:4100; Vector Backbone:pBad-modified; Vector Types:Bacterial Expression; Bacterial Resistance:Ampicillin | Addgene | 2026-11-14 12:57:05 | 0 | ||
|
JDS94 Resource Report Resource Website 1+ mentions |
RRID:Addgene_40322 | Ampicillin | Backbone contains NNN/G 0.5 Domain TAL N-terminal: ∆152 (Miller et al. 2011) TAL C-terminus: +63 (Miller et al. 2011) FOKI: ELD (-) heterodimer (Doyon et al. 2011) | Backbone Size:6447; Vector Backbone:JDS94; Vector Types:Mammalian Expression; Bacterial Resistance:Ampicillin | Addgene | 2026-11-14 12:57:06 | 1 | ||||
|
JDS92 Resource Report Resource Website 1+ mentions |
RRID:Addgene_40321 | Ampicillin | Backbone contains SHD/C 0.5 Domain TAL N-terminal: ∆152 (Miller et al. 2011) TAL C-terminus: +63 (Miller et al. 2011) FOKI: ELD (-) heterodimer (Doyon et al. 2011) | Backbone Size:6447; Vector Backbone:JDS92; Vector Types:Mammalian Expression; Bacterial Resistance:Ampicillin | Addgene | 2026-11-14 12:57:06 | 1 | ||||
|
pDDGFP-B Resource Report Resource Website 1+ mentions |
RRID:Addgene_40287 | ddGFP-B | Synthetic | Ampicillin | PMID:23656278 | Backbone Marker:Invitrogen; Backbone Size:4100; Vector Backbone:pBad-modified; Vector Types:Bacterial Expression; Bacterial Resistance:Ampicillin | Addgene | 2026-11-14 12:57:05 | 2 | ||
|
JDS90 Resource Report Resource Website 1+ mentions |
RRID:Addgene_40320 | Ampicillin | Backbone contains SNI/A 0.5 Domain TAL N-terminal: ∆152 (Miller et al. 2011) TAL C-terminus: +63 (Miller et al. 2011) FOKI: ELD (-) heterodimer (Doyon et al. 2011) | Backbone Size:6447; Vector Backbone:JDS90; Vector Types:Mammalian Expression; Bacterial Resistance:Ampicillin | Addgene | 2026-11-14 12:57:06 | 1 | ||||
|
pUAST-NaChBac Resource Report Resource Website 1+ mentions |
RRID:Addgene_40283 | NaChBac | Ampicillin | PMID:16407556 | Backbone Size:8914; Vector Backbone:pUAST; Vector Types:; Bacterial Resistance:Ampicillin | Addgene | 2026-11-14 12:57:05 | 1 |
Can't find your Plasmid?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. If you want to find a specific plasmid, it's easier to enter an RRID or an Addgene Catalog Number to search. You can refine the search results using Facets on the left side of the search results page. If you are on the table view, you can also search in a specific column by clicking the column title and enter the keywords.
If you still could not find your plasmid in the search results, please help us by registering it into the system — it's easy. Register it with Addgene.
Welcome to the NIF Resources search. From here you can search through a compilation of resources used by NIF and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that NIF has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on NIF then you can log in from here to get additional features in NIF such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into NIF you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.